Cosmetic surgery practice’s stem cell use runs afoul of FDA
The U.S. Food and Drug Administration has cited a plastic surgery practice over several violations tied to its use of adult stem cells for breast augmentation and other procedures to manufacturing violations. In a warning letter to Dr. Thomas E. Young, the owner and medical director of Young Medical Spa, the FDA’s Center for Biologics […]